SEC Form 4 · accession 0001437749-15-022570
VIVEVE MEDICAL, INC. · VIVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Durbin
Officer — Chief Financial Officer
Period of report
Dec 16, 2015
Accepted (ET)
Dec 18, 2015 · 9:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879682
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Purchase)F1 | $0.75 | Dec 16, 2015 | A | 774,001 | A | — | Dec 16, 2025 | Common Stock | 774,001 | 1,239,000 | D |
| Warrant to Purchase Common StockF2 | $0.50 | holding | — | — | — | Feb 17, 2015 | Feb 17, 2025 | Common Stock | 208,140 | 208,140 | D |
Explanation of responses
- F1The reporting person is a participant in the Issuer's 2013 Stock Option and Incentive Plan, as amended, and received 774,001 incentive stock options on December 16, 2015. The incentive stock options will vest as follows: (i) the right to purchase 25% of the common stock will vest on the first anniversary of the grant date and (ii) the right to purchase the remaining shares of common stock will vest in equal increments over 36 months.
- F2The grant of this warrant was reported on February 18, 2015.